MP:0001273 | decreased metastatic potential | |
Show
Allelic Composition: Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
|
MP:0002169 | no phenotype detected | "normal, viable and fertile appearance and behavior; indistinguishable from controls" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
Allelic Composition: Pld1tm1.1Mafr/Pld1tm1.1Mafr,Pld2tm1Yaka/Pld2tm1Yaka Genetic Background: involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj
|
MP:0002599 | increased mean platelet volume | "increased content of platelet cells over the norm" [cml:Cathleen M. Lutz, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Tbx21tm1.1(flpe/ERT2)Gmld/Tbx21tm1.1(flpe/ERT2)Gmld Genetic Background: involves: 129S2/SvPas * C57BL/6
|
MP:0003447 | reduced tumor growth/size | "less than expected development of tumorous growth when compared to controls" [anna:Anna Anagnostopoulos, Mouse Genome Informatics Curator, J:65383] |
Show
Allelic Composition: Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
|
MP:0005166 | decreased susceptiblity to injury | "less than the normal reaction to trauma, especially that by physical means" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Tbx21tm1.1(flpe/ERT2)Gmld/Tbx21tm1.1(flpe/ERT2)Gmld Genetic Background: involves: 129S2/SvPas * C57BL/6
|
MP:0005464 | abnormal platelet physiology | "atypical response of the non-nucleated cells found in the blood and involved in blood coagulation" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
|
MP:0005584 | abnormal enzyme/coenzyme activity | "altered ability of any of these proteins, or their cofactors, to act as catalysts to induce chemical changes in other substances" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Kmt2dGt(RRT024)Byg/Kmt2dGt(RRT024)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
|
MP:0005602 | decreased angiogenesis | "reduced process of blood vessel formation and the subsequent remodeling process; does not refer to the initial establishment of the vascular network" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
|
MP:0006058 | decreased cerebral infarction size | "decreased size of necrotic area of the cerebrum resulting from a sudden insufficiency of arterial or venous blood supply " [RGD:Rat Genome Database submission, smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Tbx21tm1.1(flpe/ERT2)Gmld/Tbx21tm1.1(flpe/ERT2)Gmld Genetic Background: involves: 129S2/SvPas * C57BL/6
Allelic Composition: Pld1tm3Mafr/Pld1tm3Mafr,Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg Genetic Background: involves: C57BL/6 * C57BL/6NTac
|
MP:0006059 | decreased susceptibility to ischemic brain injury | "decreased lesion size following loss of circulation in a region of the brain; may be induced or spontaneous" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Tbx21tm1.1(flpe/ERT2)Gmld/Tbx21tm1.1(flpe/ERT2)Gmld Genetic Background: involves: 129S2/SvPas * C57BL/6
Allelic Composition: Pld1tm3Mafr/Pld1tm3Mafr,Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg Genetic Background: involves: C57BL/6 * C57BL/6NTac
|
MP:0006298 | abnormal platelet activation | "anomaly in the series of progressive, overlapping events triggered by exposure of platelets to signals from subendothelial tissue, including shape change, adhesiveness, aggregation, and release reactions; when carried through to completion, these events lead to the formation of a stable hemostatic plug" [GO:0030168, MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Kmt2dGt(RRT024)Byg/Kmt2dGt(RRT024)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6J
Allelic Composition: Pld1tm3Mafr/Pld1tm3Mafr,Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg Genetic Background: involves: C57BL/6 * C57BL/6NTac
|
MP:0008260 | abnormal autophagy | "abnormal catabolic process involving the degradation of a cell s own components through the lysosomal machinery" [MGI:honda "Hiraoki Onda, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Fkrptm1Scbr/Fkrptm1Scbr,Sox1tm1(cre)Take/Sox1+,Tg(CAG-LARGE)126Fmu/0 Genetic Background: involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj
|
MP:0009549 | impaired platelet aggregation | "decrease in the ability of one platelet to one or more other platelets via adhesion molecules" [GO:0070527] |
Show
Allelic Composition: Tbx21tm1.1(flpe/ERT2)Gmld/Tbx21tm1.1(flpe/ERT2)Gmld Genetic Background: involves: 129S2/SvPas * C57BL/6
|
MP:0009764 | decreased sensitivity to induced morbidity/mortality | "increase in the amount of an external agent required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Tbx21tm1.1(flpe/ERT2)Gmld/Tbx21tm1.1(flpe/ERT2)Gmld Genetic Background: involves: 129S2/SvPas * C57BL/6
|
MP:0010144 | abnormal tumor vascularization | "aberrant process of blood vessel formation and the subsequent remodeling process within and/or around tumors" [MGI:mnk "Michelle Knowlton, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc,Tg(Mx1-cre)1Cgn/0 Genetic Background: involves: C57BL/6 * CBA
|
MP:0011100 | complete preweaning lethality | "death of all organisms of a given genotype in a population between fertilization and weaning age (Mus: approximately 3-4 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Pitx2tm1b(EUCOMM)Wtsi/Pitx2+ Genetic Background: C57BL/6N-Pitx2tm1b(EUCOMM)Wtsi/H
|
MP:0020408 | altered susceptibility to induced thrombosis | "any anomaly in the formation of thrombi following mechanical or chemical stimulation of thrombosis" [PMID:16614756, PMID:9262402] |
Show
Allelic Composition: Pld1tm3Mafr/Pld1tm3Mafr,Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg Genetic Background: involves: C57BL/6 * C57BL/6NTac
|